Поисковый запрос: (<.>A=Thiemermann, Christoph$<.>) |
Общее количество найденных документов : 31
Показаны документы с 1 по 20
|
|
1.
| Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion // J. Pharmacol. and Exp. Ther., 2005. Vol. 312, N 3.-С.1170-1178
|
2.
| Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rat. A role for glycogen synthase kinase-3'бета' // Diabetes, 2009. Vol. 58, N 1.-С.235-242
|
3.
| Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury // Arteriosclerosis, Thrombosis, and Vasc. Biol., 2009. Vol. 29, N 10.-С.1509-1515
|
4.
| Sivarajah The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-'гамма' antagonist // J. Pharmacol. and Exp. Ther., 2005. Vol. 313, N 2.-С.896-901
|
5.
| Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis // Eur. J. Pharmacol., 2000. Vol. 406, N 1.-С.127-137
|
6.
| Thiemermann Corticosteroids and cardioprotection // Nature Med., 2002. Vol. 8, N 5.-С.453-455
|
7.
| Thiemermann Corticosteroids and cardioprotection // Nature Med., 2002. Vol. 8, N 5.-С.453-455
|
8.
| Thiemermann The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis // Eur. J. Pharmacol., 1988. Vol. 155, N 1 - 2.-С.57-67
|
9.
| Thiemermann Role of endothelium-derived vasoactive mediators in myocardial ishaemia // Pol. J. Pharmacol. and Pharm., 1992. Vol. 44, Suppl..-С.73-74
|
10.
| Sprague Randy S. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits // Proc. Nat. Acad. Sci. USA, 1992. Vol. 89, N 18.-С.8711-8715
|
11.
| Walder Claire E. N-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat // Brit. J. Pharmacol., 1992. Vol. 107, N 2.-С.476-480
|
12.
| Endothelins release tissue plasminogen activator and prostanoids // Eur. J. Pharmacol., 1990. Vol. 186, N 2-3.-С.205-212
|
13.
| Schror Protection of the ischemic myocardium from reperfusion injury by prostaglandin E[1] inhibition of ischemia-induced neutrophil activation // Naunyn Schmiedebergs Arch. Pharmacol., 1988. Vol. 338, N 3.-С.268-274
|
14.
| Endothelin-3: selectivity as an antiaggregatory peptide in vivo // Eur. J. Pharmacol., 1989. Vol. 166, N 2.-С.335-338
|
15.
| Schror Eicosanoids in myocardial ischemia // Biomed. biochim. acta, 1989. Vol. 48, N 10.-С.729-734
|
16.
| Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis // Eur. J. Pharmacol., 2000. Vol. 406, N 1.-С.127-137
|
17.
| Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo // Eur. J. Pharmacol., 1993. Vol. 250, N 1.-С.157-160
|
18.
| Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo // Eur. J. Pharmacol., 1993. Vol. 250, N 1.-С.157-160
|
19.
| Thiemermann Inhibition des NO synthases dans la defaillance circulatoire: Effet benefique ou deletere? // M/S: Med. sci., 1995. Vol. 11, N 12.-С.1643-1651
|
20.
| Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo // Eur. J. Pharmacol., 1993. Vol. 250, N 1.-С.157-160
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"